Search results
Results from the WOW.Com Content Network
The chief executive of the agency is Yasuhiro Fujiwara, former head of the National Cancer Center Japan. From 2008 to 2018, the chief executive of the agency was Tatsuya Kondo, a neurosurgeon and graduate of the University of Tokyo.
The Japanese Adverse Drug Event Report (JADER) database is a spontaneous reporting system of drug adverse events which is managed by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. [1] It has been available since 2012. [1]
As a result, the market for medical device technology will expand at a CAGR of 4.9% from 2022 to 2027. Growth is predicted from $465.5 billion in 2022 to $591.3 billion in 2027.
This article needs to be updated.The reason given is: there was a significant revision to Japan's Pharmaceuticals and Medical Devices Act (PMD Act) in December 4, 2019 (令和 元 年12月 4日) and certain articles in this revised PMD Act took effect April 1, 2020, September 1, 2020, and August 1, 2021; other articles will take effect Dec. 1, 2022 (see also: https://www.natlawreview.com ...
Nipro Corporation (ニプロ株式会社, Nipro Kabushiki-gaisha) is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange.
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web.
EU investigates fair access to China's medical device market. Philip Blenkinsop and Ingrid Melander. April 24, 2024 at 10:05 AM. By Philip Blenkinsop and Ingrid Melander.
Pages in category "Medical technology companies of Japan" The following 14 pages are in this category, out of 14 total. This list may not reflect recent changes. A.